Where does Halo Neuro, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Halo Neuro, Inc. ranks #12,031 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Halo Neuro, Inc. hold?

Halo Neuro, Inc. holds 25 US utility patents granted between 2016 and 2022, spanning 4 technology areas.

What is Halo Neuro, Inc.'s Innovation Score?

Halo Neuro, Inc. has an Innovation Score of 28.1 out of 100 (26th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Halo Neuro, Inc. focus on?

Halo Neuro, Inc.'s top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy) with 21 patents, ranking #173 of 1,943 assignees active in that subclass. Grants appear in 4 CPC subclasses total.

Is Halo Neuro, Inc.'s patent grant rate increasing or decreasing?

Halo Neuro, Inc.'s recent grant velocity is -81% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Halo Neuro, Inc.'s patents?

Halo Neuro, Inc.'s patents average 14.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Halo Neuro, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Halo Neuro, Inc.

USPTO PatentsView assignee record - 25 granted patents across 4 technology areas, recorded in grant years 2016–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Halo ranks #12,031 of 49,997 tracked US assignees by granted-patent volume, with 25 patents across 4 technology areas.

#12,031
of 49,997 US assignees by volume: 26th percentile
by Innovation Score (28.1/100): 14.3
avg claims per patent: -81%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R12031 · US Corporation #12,031 · 25 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 25 grants
UPPER-Q #12,031/49,997
PHOTO-FINISH Head Technology
CPC-NARROW A61N · 4 areas
INNOV-THIN 28.1/100
CLAIMS-RICH 14.3 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -81% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Head Technology GmbH (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Halo’s 28.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.3 pts (40%) Velocity 1.2 pts (4%) Breadth 7.1 pts (25%) Claim depth 8.6 pts (30%)

Qualcomm Incorporated · highest

85
AsterionDB · near

28
Cannuflow · near

28
Halo Neuro · this assignee

28
Pioneer DJ Coporation · near

28
Iris Automation · near

28
3D Lighting… · lowest

7

What this shows Halo's Innovation Score is 28.1/100 (26th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Halo?

Each dot is one of Halo’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Halo’s own 14.3 claims/patent is at or below the 16.4 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Halo vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Halo's grants concentrate

Halo Neuro, Inc. is a focused PatentsView assignee: 4 CPC subclasses with 84% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2019 (9 grants) versus a trough of 1 in 2016. By volume, Halo sits between Hoyt Archery, Inc. and Hermes Innovations, LLC.

Halo's three-year grant acceleration

Halo Neuro, Inc. shows 2 grants in 2022–2024 against only 11 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Hoyt Archery

25
Huizhou Happy Vap…

25
Hy-ko Products

25
Hyosung

25
Head Technology

25
Hemanext

25
Hensley Industries

25
Hermes Innovations

25
Halo Neuro ◀

25

What this shows Halo holds 25 patents at rank #12,038, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Halo

By rank, the assignees closest to #12,038 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Halo's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Halo, neither rank-band nor same-CPC leaders (those blocks stay above). In A61N (Electrotherapy), Halo ranks #173 of 1,943 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (28 here).

Pioneer DJ Coporation 28 Cannuflow, Inc. 28 Iris Automation, Inc. 28 AsterionDB, Inc. 28

Halo's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

28 26th percentile higher than 26% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2022

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Halo Neuro, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	4.0%
2017	7	28.0%
2018	4	16.0%
2019	9	36.0%
2020	2	8.0%
2022	2	8.0%

Which technologies does Halo Neuro, Inc. patent most?

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 21

A61B - DIAGNOSIS; SURGERY; Identification 19

H04R - Loudspeakers, Microphones, Gramophone Pick-ups OR Like Acoustic Electromechanical TRANSDUCERS; Deaf-aid SETS; Public Address Systems 2

H04W - Wireless Communication Networks 1

Top 4 of 4 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Halo Neuro, Inc.'s patent record in context - here's where to go next.

Halo Neuro, Inc.'s lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 84% of its portfolio - see every assignee active in that class. Explore A61N
Ranked #12,031 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Halo Neuro, Inc. against Hoyt Archery, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 28.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.